Please assess the completion status of the following clinical trial:

Trial Title: Investigation of New Intermittent Catheters in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Minimum 18 years of age and with full legal capacity~* Written informed consent and signed letter of authority and secrecy agreement given~* Willing to comply with not using analgesics 1 up to 24 hours prior to catheterization visits~* Urine Multistix negative for erythrocytes (hematuria)~Exclusion Criteria:~* Participation in any other clinical investigations during this investigation~* Known hypersensitivity towards any of the test products~* Symptoms of urinary tract infection (UTI) (Investigators judgement)~* Pregnancy or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Intermittent catheter; SpeediCath® Standard male or female (Type: ACTIVE_COMPARATOR): Participants underwent catheterization with standard of care intermittent catheter. The catheterization was performed by a trained nurse.
- New intermittent catheter Variant 1 for male or female (Type: EXPERIMENTAL): Participants underwent catheterization with the new intermittent catheter Variant 1 for males or females. The catheterization was performed by a trained nurse.
- New intermittent catheter Variant 2 for male or female (Type: EXPERIMENTAL): Participants underwent catheterization with the new intermittent catheter Variant 2 for males or females. The catheterization was performed by a trained nurse.

Based on this trial design, predict the completion outcome and termination type (if applicable).